Filing Details
- Accession Number:
- 0001181431-14-037472
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-28 16:38:55
- Reporting Period:
- 2014-11-28
- Filing Date:
- 2014-11-28
- Accepted Time:
- 2014-11-28 16:38:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1567514 | Intra-Cellular Therapies Inc. | ITCI | Pharmaceutical Preparations (2834) | 364742850 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1008890 | Moshe Alafi | C/O Alafi Capital Company, Llc 8 Admiral Drive, Suite 324 Emeryville CA 94608 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-11-28 | 35,000 | $14.75 | 3,594,783 | No | 4 | P | Indirect | Held by Alafi Capital Company, LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Held by Alafi Capital Company, LLC |
Footnotes
- Mr. Alafi is a managing partner of Alafi Capital Company, LLC and may be deemed to beneficially own the shares held by Alafi Capital Company, LLC. Mr. Alafi disclaims beneficial ownership of the securities held by Alafi Capital Company, LLC except to the extent of his pecuniary interest therein.